Hoofnagle Jh
- Epidemiology top 5%
- Hepatology top 2%
- Surgery
- Infectious Diseases
- Immunology
- Topics
- Liver Disease Diagnosis and Treatment (12 papers)Hepatitis B Virus Studies (11 papers)Hepatitis C virus research (9 papers)
- Journals
- GastroenterologyTransfusionPubMed
- Partner nations
- United States
In The Last Decade
Hoofnagle Jh
20 papers receiving 565 citations
Peers
Comparison fields: 5 of 59
- Epidemiology 522
- Hepatology 505
- Surgery 77
- Infectious Diseases 49
- Immunology 28
Countries citing papers authored by Hoofnagle Jh
This map shows the geographic impact of Hoofnagle Jh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hoofnagle Jh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hoofnagle Jh more than expected).
Fields of papers citing papers by Hoofnagle Jh
This network shows the impact of papers produced by Hoofnagle Jh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hoofnagle Jh. The network helps show where Hoofnagle Jh may publish in the future.
Co-authorship network of co-authors of Hoofnagle Jh
This figure shows the co-authorship network connecting the top 25 collaborators of Hoofnagle Jh. A scholar is included among the top collaborators of Hoofnagle Jh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hoofnagle Jh. Hoofnagle Jh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 326 | |
| 2 | Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B. | 13 |
| 3 | Therapy of chronic delta hepatitis: overview. | 3 |
| 4 | Prolonged alpha interferon therapy for chronic delta hepatitis: effect on liver histopathology. | 4 |
| 5 | 3 | |
| 6 | 41 | |
| 7 | Alpha interferon therapy of chronic delta hepatitis: a pilot study. | 2 |
| 8 | Antiviral therapy of chronic viral hepatitis. ACG Committee on FDA-Related Matters. | 9 |
| 9 | A technique for liver biopsy in Pekin ducks. | 2 |
| 10 | Specific binding of human alpha interferon to high-affinity cell-surface binding sites on peripheral blood mononuclear cells. | 10 |
| 11 | Treatment of chronic type B hepatitis. | 3 |
| 12 | The interferon system in acute and chronic viral hepatitis. | 69 |
| 13 | Chronic non-A, non-B hepatitis. | 21 |
| 14 | Chronic type B hepatitis: clinical course. | 2 |
| 15 | Natural history of chronic type B hepatitis. | 35 |
| 16 | 11 | |
| 17 | Current concepts in viral hepatitis. | 1 |
| 18 | The prevalence of hepatitis B surface antigen in commercially prepared plasma products. | 33 |
| 19 | 9 | |
| 20 | Transmission of viral hepatitis, type B, by plasma derivatives. | 6 |
About Hoofnagle Jh
Hoofnagle Jh is a scholar working on Hepatology, Epidemiology and Animal Science and Zoology, having authored 20 papers that have together received 603 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (12 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis C virus research (9 papers). The work is most often cited by research in Hepatology (505 citations), Epidemiology (522 citations) and Transplantation (14 citations). Hoofnagle Jh has collaborated with scholars based in United States. Frequent co-authors include John R. Lake, Yue Wei, James Dooley, Matthew Peters, HJ Alter, AM Di Bisceglie, MW Fried, Edward Tabor, N. Nath and John Vergalla. Their work appears in journals such as Gastroenterology, Transfusion and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.